作者：
Andrew J,Song [1]
;
Keyue,Ding [2]
;
Iyad,Alnahhas [3]
;
Normand J,Laperriere [4]
;
James,Perry [5]
;
Warren P,Mason [6]
;
Chad,Winch [2]
;
Chris J,O'Callaghan [2]
;
Johan J,Menten [7]
;
Alba A,Brandes [8]
;
Claire,Phillips [9]
;
Michael F,Fay [10]
;
Ryo,Nishikawa [11]
;
David,Osoba [12]
;
J Gregory,Cairncross [13]
;
Wilson,Roa [14]
;
Wolfgang,Wick [15]
;
Wenyin,Shi [1]
作者单位：
Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
[1]
Department of Public Health Sciences, Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.
[2]
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
[3]
Department of Radiation Oncology, Princess Margaret Cancer Center, Toronto, Ontario, Canada.
[4]
Department of Medicine, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
[5]
Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
[6]
Department of Experimental Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
[7]
Department of Medical oncology, IRCCS Istituto Scienze Neurologiche - Bologna, Italy.
[8]
Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
[9]
Genesis Cancer Care, Newcastle, NSW, Australia.
[10]
Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Hidaka, Japan.
[11]
QOL Consulting, West Vancouver, British Columbia, Canada.
[12]
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
[13]
Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.
[14]
Division of Neurology, Heidelberg University Medical Center, Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
[15]
DOI
10.1093/noajnl/vdac011
PMID
35098127
发布时间
2022-04-28
换一批
换一批
